nad has been researched along with Alcoholic Fatty Liver in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (42.11) | 18.7374 |
1990's | 3 (15.79) | 18.2507 |
2000's | 1 (5.26) | 29.6817 |
2010's | 7 (36.84) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bao, Z; Chen, Y; Huang, S; Li, X; Liu, H; Liu, Y; Song, Z; Wang, Z; Zhang, B | 1 |
Fan, R; Huang, Y; Qian, X; Ruan, HB; Sun, X; Wang, Q; Xiong, X; Xu, L; Yu, J; Zhang, C | 1 |
Duffield, GE; Liangpunsakul, S; Pywell, CM; Ross, RA; Zhou, P | 1 |
Jia, W; Li, Q; Sun, X; Tan, X; Xie, G; Zhang, W; Zhong, W; Zhou, Z | 1 |
Harimoto, N; Ikegami, T; Konishi, H; Maehara, Y; Nakagawara, H; Oda, Y; Shirabe, K; Soejima, Y; Yamashita, Y; Yoshizumi, T | 1 |
Choi, Y; Kim, A; Kim, HJ; Kim, JW; Lee, KS; Lee, YJ; Seok, JW; Song, SJ; Yu, JH | 1 |
Auwerx, J; Bai, P; Boulares, AH; Cao, Z; Gao, B; Gariani, K; Godlewski, G; Haskó, G; Holovac, E; Horváth, B; Liaudet, L; Mukhopadhyay, P; Nemeth, BT; Pacher, P; Paloczi, J; Park, O; Persidsky, Y; Rajesh, M; Ryu, D; Varga, ZV; Wang, W; Xu, MJ; Zhou, Z | 1 |
Gao, B; Purohit, V; Song, BJ | 1 |
Seitz, HK | 1 |
Gordon, ER | 1 |
Lieber, CS | 1 |
Bartlett, K; Eaton, S; Record, CO | 2 |
Cronholm, T; Yu, BY | 1 |
Brandt, KH; Bronkhorst, FB | 1 |
Badawy, AA | 1 |
Ryle, PR | 1 |
Ihori, M | 1 |
Dianzani, MU | 1 |
5 review(s) available for nad and Alcoholic Fatty Liver
Article | Year |
---|---|
Molecular mechanisms of alcoholic fatty liver.
Topics: Animals; Complement C3; Fatty Liver, Alcoholic; Humans; NAD; PPAR alpha; Sterol Regulatory Element Binding Proteins; Tumor Necrosis Factor-alpha | 2009 |
Metabolism and metabolic effects of ethanol.
Topics: Acetaldehyde; Alcoholic Beverages; Carbohydrate Metabolism; Collagen; Ethanol; Fatty Liver, Alcoholic; Lipid Metabolism; Lipid Peroxides; Liver; Liver Cirrhosis, Alcoholic; Liver Regeneration; Microsomes, Liver; Microtubules; Mitochondria, Liver; Models, Biological; NAD; Necrosis; Oxidation-Reduction | 1981 |
Multiple biochemical effects in the pathogenesis of alcoholic fatty liver.
Topics: Ethanol; Fatty Acids; Fatty Liver, Alcoholic; Humans; Lipids; Liver; NAD; Oxidation-Reduction; Triglycerides | 1997 |
[Alcohol, liver and pancreas].
Topics: Acute Disease; Alcohol Oxidoreductases; Alcoholism; Chronic Disease; Fatty Liver, Alcoholic; Female; Hepatitis, Alcoholic; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Male; Microsomes, Liver; NAD; Pancreatitis; Sex Factors | 1979 |
[Alcoholic liver injuries].
Topics: Acetaldehyde; Animals; Ethanol; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Liver; Liver Diseases, Alcoholic; NAD; Rats | 1985 |
14 other study(ies) available for nad and Alcoholic Fatty Liver
Article | Year |
---|---|
Poly(ADP-Ribose) Polymerase Inhibitor PJ34 Attenuated Hepatic Triglyceride Accumulation in Alcoholic Fatty Liver Disease in Mice.
Topics: Animals; Fatty Liver, Alcoholic; Gene Expression Regulation, Enzymologic; Intracellular Space; Liver; Male; Mice; Mice, Inbred C57BL; NAD; Phenanthrenes; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Triglycerides | 2018 |
NAMPT overexpression alleviates alcohol-induced hepatic steatosis in mice.
Topics: Adenoviridae; Animals; Cells, Cultured; Cytokines; Disease Models, Animal; Down-Regulation; Ethanol; Fatty Liver, Alcoholic; Gene Knockdown Techniques; Genetic Therapy; Hepatocytes; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Nicotinamide Phosphoribosyltransferase; Recombinant Fusion Proteins; Sirtuin 1; Sirtuins; Triglycerides; Up-Regulation | 2019 |
Disturbances in the murine hepatic circadian clock in alcohol-induced hepatic steatosis.
Topics: Animals; Bile Acids and Salts; Circadian Clocks; Circadian Rhythm; Disease Models, Animal; Ethanol; Fatty Liver, Alcoholic; Gene Expression Profiling; Gene Expression Regulation; Lipid Metabolism; Liver; Male; Mice; NAD; Period Circadian Proteins | 2014 |
Dietary nicotinic acid supplementation ameliorates chronic alcohol-induced fatty liver in rats.
Topics: 3-Hydroxybutyric Acid; Acyl-CoA Oxidase; Adiponectin; Animals; Chronic Disease; Cytochrome P-450 CYP4A; Diet; Dietary Supplements; Ethanol; Fatty Acid Synthase, Type I; Fatty Liver, Alcoholic; Liver; Male; Metabolomics; NAD; Niacin; Rats; Ubiquitination | 2014 |
Suppression of silent information regulator 1 activity in noncancerous tissues of hepatocellular carcinoma: Possible association with non-B non-C hepatitis pathogenesis.
Topics: Acetylation; Animals; Carcinoma, Hepatocellular; Case-Control Studies; Cell Hypoxia; Fatty Liver, Alcoholic; Female; Gene Expression Regulation; Hep G2 Cells; Hepatitis; Hepatitis B; Hepatitis C; Histones; Humans; Liver Neoplasms; Mice, Inbred C57BL; NAD; Non-alcoholic Fatty Liver Disease; Pregnancy; Retrospective Studies; Sirtuin 1 | 2015 |
Suppression of PPARγ-mediated monoacylglycerol O-acyltransferase 1 expression ameliorates alcoholic hepatic steatosis.
Topics: Acyltransferases; Animals; Ethanol; Fatty Liver, Alcoholic; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAD; PPAR gamma; Real-Time Polymerase Chain Reaction; Sirtuin 1 | 2016 |
PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.
Topics: Animals; Diet, High-Fat; Disease Models, Animal; Fatty Acids; Fatty Liver, Alcoholic; Humans; Kupffer Cells; Liver; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; NAD; Nitrosative Stress; Non-alcoholic Fatty Liver Disease; Oxidative Stress; Phenanthrenes; Phthalazines; Piperazines; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Quinolines; Sirtuin 1 | 2017 |
[Metabolic aspects of alcoholic liver damage: 1984/5 update. 1. Epidemiology and alcohol metabolism].
Topics: Acetaldehyde; Acidosis; Alcohol Dehydrogenase; Alcohol Drinking; Alcohol Oxidoreductases; Collagen; Cross-Sectional Studies; Fatty Liver, Alcoholic; Humans; Ketosis; Lactates; Lactic Acid; Liver; Liver Diseases, Alcoholic; NAD; Porphyrins; Proteins; Uric Acid | 1984 |
Alcohol-induced mitochondrial changes in the liver.
Topics: Adenosine Diphosphate; Alcoholism; Animals; Fatty Acid Desaturases; Fatty Acids; Fatty Liver, Alcoholic; Humans; Lipid Peroxides; Liver Diseases, Alcoholic; Macaca nemestrina; Male; Mitochondria, Liver; NAD; Oxygen Consumption; Papio; Phospholipids; Rats | 1984 |
Mitochondrial beta-oxidation in human alcoholic liver disease.
Topics: 3-Hydroxyacyl CoA Dehydrogenases; Acyl-CoA Dehydrogenase; Fatty Acid Desaturases; Fatty Liver, Alcoholic; Humans; In Vitro Techniques; Mitochondria, Liver; NAD; Oxidation-Reduction; Triglycerides | 1995 |
Coupling of ethanol metabolism to lipid biosynthesis: labelling of the glycerol moieties of sn-glycerol-3-phosphate, a phosphatidic acid and a phosphatidylcholine in liver of rats given [1,1-2H2]ethanol.
Topics: Animals; Deuterium; Ethanol; Fatty Liver, Alcoholic; Glycerol; Glycerophosphates; Lipids; Liver; Male; NAD; Phosphatidic Acids; Phosphatidylcholines; Rats; Rats, Sprague-Dawley; Triglycerides | 1997 |
Nutrition and the biochemical pathology of the alcohol-induced liver injury.
Topics: Alcohol Dehydrogenase; Alcohol Oxidoreductases; Alcoholism; Animals; Catalase; Deficiency Diseases; Ethanol; Fatty Liver, Alcoholic; Hepatitis, Alcoholic; Humans; Liver; Liver Cirrhosis, Alcoholic; Liver Diseases, Alcoholic; Microsomes, Liver; NAD; Oxidation-Reduction; Porphyrias | 1985 |
Hepatic redox state alterations as a mechanism of fatty liver production after ethanol: fact or fiction?
Topics: Animals; Ethanol; Fatty Liver, Alcoholic; Glycerophosphates; Humans; Liver; NAD; NADP; Oxidation-Reduction; Rats | 1986 |
Lipid peroxidation in ethanol poisoning: a critical reconsideration.
Topics: Acetaldehyde; Alcoholism; Animals; Ethanol; Fatty Acids, Nonesterified; Fatty Liver, Alcoholic; Free Radicals; Glutathione; Humans; Lipid Peroxides; Liver; Malondialdehyde; NAD; Phospholipids; Thiobarbiturates | 1985 |